MYC is amplified in BRCA1-associated breast cancers.

@article{Grushko2004MYCIA,
  title={MYC is amplified in BRCA1-associated breast cancers.},
  author={Tatyana A. Grushko and James J. Dignam and Soma Das and Anne M Blackwood and Charles M. Perou and Karin K Ridderstr{\aa}le and Kristin N Anderson and Min-jie Wei and April Adams and Fitsum G. Hagos and Lise Sveen and Henry T. Lynch and Barbara L. Weber and Olufunmilayo I. Olopade},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={2004},
  volume={10 2},
  pages={499-507}
}
PURPOSE Germ-line mutations in the BRCA1 tumor suppressor gene predispose to early onset breast cancers with a distinct phenotype characterized by high tumor grade, aneuploidy, high proliferation rate, and estrogen receptor-negativity. The molecular mechanisms and cooperative oncogenes contributing to multistep tumor progression in cells lacking BRCA1 are not well defined. To examine whether C-MYC (MYC), a transforming oncogene associated with genetic instability, contributes to multistep tumor… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 34 references

Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival

  • A. Jain, K. Chin, +4 authors J. W. Gray
  • Proc. Natl. Acad. Sci. USA,
  • 2001
Highly Influential
4 Excerpts

Promoter 10 C. M. Perou, unpublished observations

  • M. Esteller, J. M. Silva, +11 authors J. G. Herman
  • Cancer Research. on November
  • 2004
1 Excerpt

Similar Papers

Loading similar papers…